entertainment -WSS

entertainment

author：knowledge 2025-08-26 10:54:10 - browse：736

Eli Lilly headquarters — Kristoffer Tripplaar/AP

SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity therapy.

The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year. The full results, published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the American Diabetes Association conference.

By the end of trial, the authors said, participants’ weight loss had not plateaued, suggesting potential for even greater weight loss over a longer treatment period.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： The explosion of genetic testing requires a new approach

focus

WSS

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

Senate committee scrutinizes Medicare Advantage brokers

House panel to mark up pandemic

The EU Joint Clinical Assessment needs to live up to its promise

How redistricting in 6 states could affect who controls Congress

Sen. Bill Cassidy on how to lower drug prices

hotspot

entertainment

leisure time

Medicare details structure of new drug price negotiation program

With fresh data, a dynamic duo powers Eli Lilly to new heights

Cancer drug shortages should be causing more outrage

HHS leader on health, climate change and biopharma emissions

Psychedelics group wrestles with new pharma identity

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How climate

Novavax promises a turnaround & Lilly roils the obesity market

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

hotspot

Why health workers in Gaza are injured or die at high rates

Solve the antibiotic resistance crisis with preventive drugs

How corporate America is slashing DEI workers amid backlash to diversity programs

STAT Summit: Michael J. Fox on progress in Parkinson's research

FDA gives detailed accounting of AI

Will Ozempic

focus

explore

Wikipedia

Wikipedia